关闭
纪雪梅
职称:副教授
邮箱:jixuemei198530@126.com
学院:生命科学与技术学院
实验室:江宁校区学院实验楼一期316室
招生学科:微生物与生化药学,生物与医药
办公室:江宁校区学院实验楼一期315室
个人简历

女,19855月生,副教授,硕士研究生导师毕业于南京师范大学生物化学与分子生物学博士学位。20137月至今,任职中国药科大学生命科学与技术学院生物化学系。主讲《生物化学》、《Being a Biomolecular Scientist 2:Biochemist》课程研究方向为抗肿瘤蛋白药物制备及作用机制研究主持纵向课题2横向课题2项,授权专利3项。参与国家科技部重大新药创制临床前项目、藏医药协同创新项目山东省自然科学基金多项省部级课题


研究方向


蛋白药物表达及作用机制研究


主持在研项目情况

(1)国家自然科学基金青年基金项目:基于肿瘤EMT炎症微环境的Anti-TNFa-VHH-RGD4C融合纳米抗体设计及作用机制研究,主持,2017.1-2019.12

(2)江苏省自然科学基金青年基金项目:基于肿瘤内部转移性炎症微环境的TNFα融合纳米抗体设计及对乳腺癌作用研究,主持,2016.7-2019.6

(3)横向课题项目:新型生发液安全性及功能性评价,主持,2023.1-2024.12

近年代表性科研成果


[1] Kang N, Liang X, Fan B, Zhao C, Shen B, Ji X*, Liu Y*. Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance. Cancers (Basel). 2022 Nov 18;14(22):5681.

[2] Kang N, Zhou J, Liang X, Li J, Han T, Zhao C, Yang T, Ji X*, Liu Y*. Tumor necrosis factor α inhibition overcomes immunosuppressive M2b macrophage-induced bevacizumab resistance in triple-negative breast cancer. Cell Death Dis. 2020 Nov 19;11(11):993.

[3] Ji X# Han T#, Kang N, Huang S, Liu Y. Preparation of RGD4C fused anti-TNFα nanobody and inhibitory activity on triple-negative breast cancer in vivo. Life Sci. 2020 Nov 1;260:118274.

[4] Ji X#, Wang H#, Chen Y, Zhou J, Liu Y. Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood-brain barrier and target glioma. AMB Express. 2019 Oct 15;9(1):165.

[5] Qiao Z, Li X, Kang N, Yang Y, Chen C, Wu T, Zhao M, Liu Y*, Ji X*. A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy. Int J Mol Sci. 2019 Feb 28;20(5):1057.

[6] Chen C, Li X, Gu M, Di R, Kang N, Wang L, Lai Y, Liu Y*, Ji X*. Biological characterisation and application of human MTH1 and monoclonal antibody preparation. Oncol Rep. 2019 Mar;41(3):1851-1862. doi: 10.3892/or.2018.6942. Epub 2018 Dec 19. PMID: 30569141.

[7] Xiong C, Mao Y, Wu T, Kang N, Zhao M, Di R, Li X, Ji X*, Liu Y*. Optimized Expression and Characterization of a Novel Fully Human Bispecific Single-Chain Diabody Targeting Vascular Endothelial Growth Factor165 and Programmed Death-1 in Pichia pastoris and Evaluation of Antitumor Activity In Vivo. Int J Mol Sci. 2018 Sep 25;19(10):2900.

[8] Ji X#, Peng Z#, Li X, Yan Z, Yang Y, Qiao Z, Liu Y. Neutralization of TNFα in tumor with a novel nanobody potentiates paclitaxel-therapy and inhibits metastasis in breast cancer. Cancer Lett. 2017 Feb 1;386:24-34.